Potential Use of Antiviral Agents in Polio Eradication

De Palma, Armando M.; Pürstinger, Gerhard; Wimmer, Eva; Patick, Amy K.; Andries, Koen; Rombaut, Bart; De Clercq, Erik; Neyts, Johan

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Potential Use of Antiviral Agents in Polio Eradication

Published Date:

Apr 2008

Source:

Emerg Infect Dis. 14(4):545-551.

[PDF-226.51 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

De Palma, Armando M. ; Pürstinger, Gerhard ; Wimmer, Eva ; Patick, Amy K. ; Andries, Koen ; ... More ▼

Description:

In 1988, the World Health Assembly launched the Global Polio Eradication Initiative, which aimed to use large-scale vaccination with the oral vaccine to eradicate polio worldwide by the year 2000. Although important progress has been made, polio remains endemic in several countries. Also, the current control measures will likely be inadequate to deal with problems that may arise in the postpolio era. A panel convoked by the National Research Council concluded that the use of antiviral drugs may be essential in the polio eradication strategy. We here report on a comparative study of the antipoliovirus activity of a selection of molecules that have previously been reported to be inhibitors of picornavirus replication and discuss their potential use, alone or in combination, for the treatment or prophylaxis of poliovirus infection.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	07-0439-F1.gif	image/gif
	07-0439-F1.jpg	image/jpeg
	07-0439-F2.gif	image/gif
	07-0439-F2.jpg	image/jpeg
	07-0439_finalS.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs

Personal Author:

Duintjer Tebbens, Radboud J.; Pallansch, Mark A.; Thompson, Kimberly M.;

Published Date:

Sep 17 2015

Source:

BMC Infect Dis. 15.

Description:

BackgroundA small number of individuals with B-cell-related primary immunodeficiency diseases (PIDs) may exhibit long-term (prolonged or chronic) excretion of immunodeficiency-associated vaccine-derived polioviruses (iVDPVs) following infection with ...

File Type:

[PDF - 1.30 MB]
Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era

Personal Author:

Bandyopadhyay, Ananda S.; Singh, Harpal; Fournier-Caruana, Jacqueline; Modlin, John F.; Wenger, Jay; Partridge, Jeffrey; Sutter, Roland W.; Zaffran, Michel J.;

Published Date:

July 17 2019

Source:

Emerg Infect Dis. 25(7):1363-1369

Description:

The Global Polio Eradication Initiative continues to make progress toward the eradication target. Indigenous wild poliovirus (WPV) type 2 was last detected in 1999, WPV type 3 was last detected in 2012, and over the past 2 years WPV type 1 has been d...

File Type:

[PDF - 2.45 MB]
Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame

Personal Author:

Duintjer Tebbens, Radboud J.; Pallansch, Mark A.; Wassilak, Steven G. F.; Cochi, Stephen L.; Thompson, Kimberly M.;

Published Date:

Mar 24 2016

Source:

BMC Infect Dis. 16.

Description:

BackgroundFollowing successful eradication of wild polioviruses and planned globally-coordinated cessation of oral poliovirus vaccine (OPV), national and global health leaders may need to respond to outbreaks from reintroduced live polioviruses, part...

File Type:

[PDF - 2.14 MB]
Dominant drug targets suppress the emergence of antiviral resistance

Personal Author:

Tanner, Elizabeth J; Liu, Hong-mei; Oberste, M Steven; Pallansch, Mark; Collett, Marc S; Kirkegaard, Karla;

Published Date:

Nov 03 2014

Source:

eLife. 3.

Description:

The emergence of drug resistance can defeat the successful treatment of pathogens that display high mutation rates, as exemplified by RNA viruses. Here we detail a new paradigm in which a single compound directed against a 'dominant drug target' supp...

File Type:

[PDF - 2.17 MB]
Vaccine-Derived Poliovirus Infection among Patients with Primary Immunodeficiency and Effect of Patient Screening on Disease Outcomes, Iran

Personal Author:

Shaghaghi, Mohammadreza; Shahmahmoodi, Shohreh; Nili, Ali; Abolhassani, Hassan; Madani, Seyedeh Panid; Nejati, Ahmad; Yousefi, Maryam; Kandelousi, Yaghoob M.; Irannejad, Mona; Shaghaghi, Shiva; Zahraei, Seyed Mohsen; Mahmoudi, Sussan; Gouya, Mohammad Mehdi; Yazdani, Reza; Azizi, Gholamreza; Parvaneh, Nima; Aghamohammadi, Asghar;

Published Date:

November 2019

Source:

Emerg Infect Dis. 25(11):2005-2012

Description:

Patients with immunodeficiency-associated vaccine-derived poliovirus (iVDPV) are potential poliovirus reservoirs in the posteradication era that might reintroduce polioviruses into the community. We update the iVDPV registry in Iran by reporting 9 ne...

File Type:

[PDF - 894.50 KB]